Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-08

Clinical Trial Update: Anti-inflammatory Treatment for Inactive Takayasu Arteritis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update reports ongoing evaluation of anti-inflammatory treatment for inactive Takayasu arteritis, with the study status currently unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Takayasu Arteritis, Anti-Inflammatory Agents | Phase 2, Phase 3 | Status: UNKNOWN